(Note: Onion Global sharply downsized its IPO at pricing on May 6, 2021, to 9.31 million American Depositary Shares (ADS), down from 12.5 million ADS in the prospectus, at $7.25 – the low end of its $7.25-to-$9.25 range – to raise $67.5 million. Ten (10) ADS represent 1 Class A ordinary share. Onion Global Limited […]

(Note: This is a blank check IPO of Class A ordinary shares and NOT units. ION Acquisition Corp. 3 was incorporated in the Cayman Islands.) We intend to focus on the rapidly growing universe of Israeli companies and entrepreneurs that apply technology and innovation to everyday lives. We will utilize the expertise and capabilities of […]

We are a newly incorporated blank check company formed as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any […]

(Note: This is NOT a traditional IPO. This is a NASDAQ uplisting from the OTCQB. IPOScoop has “NO CALL” on this offering because it is an uplisting. The assumed public offering price is $4.10, where Red Cat’s shares closed on April 23, 2021, on the OTCQB. The company describes this as “a firm commitment initial […]

(Note: iPower priced its IPO on May 11, 2021, at $5 – sharply below its $7-to-$9 price range – on 3.36 million shares, up from 3 million in the downsized terms in the prospectus, to raise $16.8 million. On May 7, 2021, iPower slashed the size of its IPO to 3 million shares at $7 […]

 We were founded in Brazil 17 years ago as a bootstrapped startup in a garage. Our unified end-to-end customer experience (CX) communications platform provides companies with (i) solutions focused on campaigns, sales teams, customer service and engagement, (ii) tools such as software application programming interfaces (APIs), chatbots, single customer view, journey designer, documents composer and authentication and (iii) channels […]

We are a clinical stage biopharmaceutical company applying our pioneering DARPin® product candidates to treat serious diseases, with a current focus on infectious disease, oncology and ophthalmology. Our DARPin platform, which is designed using ankyrin repeat proteins, allows us to build product candidates with multiple mechanisms of action to address complex biological problems, while potentially […]

Note: Actress Jessica Alba founded The Honest Co. in 2012. In her Founder’s Letter, she writes about her life – born into a hardworking Mexican-American family – and the hardship of suffering from severe asthma and allergies as a child. She was inspired to create this company after suffering a severe allergic reaction to laundry […]

We are a preclinical biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. We are leveraging our proprietary PREDATORTM platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional pro-inflammatory immune therapies. Our molecules, […]

(Note: Privia Health priced its upsized IPO on April 28, 2021, at $23 – the top of its upwardly revised range of $21 to $23 – on 19.5 million shares, the same number as in the prospectus, to raise $448.5 million. Privia had increased its price range to $21 to $23, up from $17 to […]